These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. THE EFFECT OF STREPTOKINASE ON THE PLATELET AGGREGATES IN ARTIFICIAL IN VITRO THROMBOSIS. ROZENBERG MC Aust J Exp Biol Med Sci; 1965 Jun; 43():245-54. PubMed ID: 14327521 [No Abstract] [Full Text] [Related]
4. [Clinical study of fibrinolysis activated by streptokinase]. TURPINI R Laboratorio; 1956 Jul; 11(127):1-22. PubMed ID: 13358195 [No Abstract] [Full Text] [Related]
5. FIBRINOGEN BREAKDOWN PRODUCTS. LEWIS JH; WILSON JH Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449 [No Abstract] [Full Text] [Related]
6. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
7. ON THE PLASMINOGEN ACTIVATOR FORMING CAPACITY OF HUMAN PLASMA GLOBULINS REACTING WITH STREPTOKINASE. AUERSWALD W; DOLESCHEL W Med Exp Int J Exp Med; 1964; 10():179-84. PubMed ID: 14129855 [No Abstract] [Full Text] [Related]
8. FIBRINOLYTIC ACTIVITY OF TISSUE SECTIONS OF THE DOG KIDNEY. PROKOPOWICZ J; REJNIAK L; NIEWIAROWSKI S; WOROWSKI K Thromb Diath Haemorrh; 1964 Dec; 12():396-406. PubMed ID: 14254699 [No Abstract] [Full Text] [Related]
9. Analysis of the streptokinase activated fibrinolysis by means of thrombelastography. DE NICOLA P; MAZZETTI GM Blut; 1957 Jan; 3(1):20-6. PubMed ID: 13412773 [No Abstract] [Full Text] [Related]
10. ON THE SUBSTRATE CHARACTERISTICS OF 5-HYDROXYTRYPTAMINE-CERULOPLASMIN TREATED HUMAN FIBRIN EXPOSED TO FIBRINOLYTIC AGENTS. AUERSWALD W; BERNHEIMER H; DOLESCHEL W Med Pharmacol Exp Int J Exp Med; 1965; 12():81-91. PubMed ID: 14279888 [No Abstract] [Full Text] [Related]
11. [Thromboelastographical determination of fibrinolysis activated with streptokinase in labor and puerperium]. COTTAFAVI M Riv Ostet Ginecol; 1955 Jul; 10(7):490-8. PubMed ID: 13267362 [No Abstract] [Full Text] [Related]
12. [The role of activator in the degeneration of human fibrin coagulum. First results with a new unit technic]. von KAULLA K Klin Wochenschr; 1960 Mar; 38():288-90. PubMed ID: 14404919 [No Abstract] [Full Text] [Related]
13. Studies on the activating factors in fibrinolytic system. II. Streptococcal and staphylococcal fibrinolysis. HAYASHI T; MAEKAWA S Jpn J Exp Med; 1954 Oct; 24(5):287-305. PubMed ID: 13242259 [No Abstract] [Full Text] [Related]
14. [ON THE MECHANISM OF FIBRINOLYSIS CAUSED BY STREPTOKINASE]. SCHMIDT HW Klin Wochenschr; 1963 Dec; 41():1200-3. PubMed ID: 14107275 [No Abstract] [Full Text] [Related]
15. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION. GODAL HC; HELLE I Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280 [No Abstract] [Full Text] [Related]
16. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related]
17. THE QUANTITATIVE DETERMINATION OF FIBRINOLYTIC INHIBITORS IN PLASMA OR SERUM BY MEANS OF THE FIBRIN PLATE. BLIX S Scand J Clin Lab Invest; 1964; 16():403-8. PubMed ID: 14202020 [No Abstract] [Full Text] [Related]
18. POST MORTEM ACTIVATION OF HUMAN BLOOD FIBRINOLYTIC ENZYME IN SUDDEN AND NATURAL DEATHS. HABA K; KUMANO O; MOHRI M; TAKEMARU H; KAWANISHI K; TOBE S; KAMADA T; UENO S Acta Med Okayama (1952); 1963; 17():279-88. PubMed ID: 14168972 [No Abstract] [Full Text] [Related]